- Home
- DRIO vs ALUR Comparison
DRIO vs ALUR Comparison
Compare DRIO & ALUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DRIO
- ALUR
- Stock Information
- Founded
- DRIO 2011
- ALUR 2009
- Country
- DRIO United States
- ALUR United States
- Employees
- DRIO N/A
- ALUR N/A
- Industry
- DRIO Medical/Dental Instruments
- ALUR
- Sector
- DRIO Health Care
- ALUR
- Exchange
- DRIO Nasdaq
- ALUR Nasdaq
- Market Cap
- DRIO 28.3M
- ALUR 22.8M
- IPO Year
- DRIO N/A
- ALUR N/A
- Fundamental
- Price
- DRIO $0.70
- ALUR $2.69
- Analyst Decision
- DRIO Strong Buy
- ALUR Strong Buy
- Analyst Count
- DRIO 2
- ALUR 3
- Target Price
- DRIO $2.50
- ALUR $22.83
- AVG Volume (30 Days)
- DRIO 138.4K
- ALUR 857.0K
- Earning Date
- DRIO 05-14-2025
- ALUR 05-14-2025
- Dividend Yield
- DRIO N/A
- ALUR N/A
- EPS Growth
- DRIO N/A
- ALUR N/A
- EPS
- DRIO N/A
- ALUR N/A
- Revenue
- DRIO $28,034,000.00
- ALUR $28,304,000.00
- Revenue This Year
- DRIO $16.54
- ALUR N/A
- Revenue Next Year
- DRIO $21.93
- ALUR $49.35
- P/E Ratio
- DRIO N/A
- ALUR N/A
- Revenue Growth
- DRIO 47.20
- ALUR N/A
- 52 Week Low
- DRIO $0.50
- ALUR $2.15
- 52 Week High
- DRIO $1.55
- ALUR $88.75
- Technical
- Relative Strength Index (RSI)
- DRIO 50.29
- ALUR 49.19
- Support Level
- DRIO $0.63
- ALUR $2.35
- Resistance Level
- DRIO $0.72
- ALUR $3.00
- Average True Range (ATR)
- DRIO 0.04
- ALUR 0.26
- MACD
- DRIO -0.00
- ALUR -0.01
- Stochastic Oscillator
- DRIO 65.14
- ALUR 37.36
About DRIO DarioHealth Corp.
DarioHealth Corp is a digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by precision data analytics, software, and personalized coaching. Its cross-functional team operates at the intersection of life sciences, behavioral science, and software technology to deliver seamlessly integrated and engaging digital therapeutics interventions. Also platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health.
About ALUR Allurion Technologies Inc.
Allurion Technologies Inc is a medical device company that focuses on creating a weight loss platform to treat overweight patients. Its platform, the Allurion Program, features the world's first and only swallowable, procedure-less intragastric balloon for weight loss and offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion VCS. Its proprietary intragastric balloon, the Allurion Balloon, is in the form of a swallowed capsule that is administered to patients under the guidance of a healthcare provider without surgery, endoscopy, or anesthesia.